Related Experiment Videos
Chemoprophylaxis of early onset Group B streptococcal disease
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chemoprophylaxis of early-onset group B streptococcal disease in 1999.
Current opinion in pediatrics·2000
Prevention of neonatal necrotizing enterocolitis.
Clinics in perinatology·1994
Development of IgM antibody to group B Streptococcus type III in human infants.
The Journal of infectious diseases·1992
Antimicrobial prophylaxis of neonatal group B streptococcal sepsis.
Clinics in perinatology·1988
Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.
The New England journal of medicine·1986
Human IgG antibody to group b Streptococcus type III: comparison of protective levels in a murine model with levels in infected human neonates.
The Journal of infectious diseases·1986
Evidence for pathogenicity of Ureaplasma urealyticum for the upper urinary tract derived from animal models.
Pediatric infectious disease·1986
Ureaplasma-eukaryotic cell interactions in vitro.
Pediatric infectious disease·1986
Mass cultivation of ureaplasmas and some applications.
Pediatric infectious disease·1986
Energy production in Ureaplasma urealyticum.
Pediatric infectious disease·1986
Metabolic distinctiveness of ureaplasmas.
Pediatric infectious disease·1986
Evidence of an immune response to Ureaplasma urealyticum in perinatal morbidity and mortality.
Pediatric infectious disease·1986
Gaps Between Prescription and Practice: Pharmacy-Based Measurement of Prophylaxis Adherence in Haemophilia.
Haemophilia : the official journal of the World Federation of Hemophilia·2026
Achieving zero open defecation status through a community-based programme in Cavite, Philippines, 2013-2019: a field review.
Western Pacific surveillance and response journal : WPSAR·2026
Perspectives on PrEP/PEP Integration in Telehealth Gender-Affirming Care: A Survey of Clients From a National Telehealth Platform.
Open forum infectious diseases·2026